Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.

Sonic Hedgehog (Shh) biomarker epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) tyrosine kinase inhibitor (TKI)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 11 01 2022
accepted: 20 01 2022
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 1 3 2022
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2021.747692.].

Identifiants

pubmed: 35223530
doi: 10.3389/fonc.2022.852540
pmc: PMC8867316
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

852540

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2022 Takam Kamga, Swalduz, Costantini, Julié, Emile, Pérol, Avrillon, Ortiz-Cuaran, De Saintigny and Giroux-Leprieur.

Auteurs

Paul Takam Kamga (P)

Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.

Aurélie Swalduz (A)

Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Adrien Costantini (A)

Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.
Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, Boulogne-Billancourt, France.

Catherine Julié (C)

Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.
Department of Pathology, APHP - Hopital Ambroise Pare, Boulogne-Billancourt, France.

Jean-François Emile (JF)

Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.

Maurice Pérol (M)

Department of Medical Oncology, Centre Léon Bérard, Lyon, France.

Virginie Avrillon (V)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Sandra Ortiz-Cuaran (S)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Pierre De Saintigny (P)

Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Etienne Giroux-Leprieur (E)

Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.
Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, Boulogne-Billancourt, France.

Classifications MeSH